ResMed (RMD) Tops Q3 EPS by 5c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $228.35 -0.37%
EPS Growth %: +5.5%
Financial Fact:
Diluted earnings per share (note 2-j): 0.54
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +5.5%
Financial Fact:
Diluted earnings per share (note 2-j): 0.54
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q3 EPS of $2.86, $0.05 better than the analyst estimate of $2.81. Revenue for the quarter came in at $1.4 billion versus the consensus estimate of $1.42 billion.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
- ICICI Bank (ICICIBC:IN) (IBN) PT Raised to INR2,000 at Goldman Sachs
- Deutsche Bank Downgrades Spire Healthcare (SPI:LN) (SRRHF) to Hold
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
